Tagged with Policy,

Mexico’s Megafarmacia – Solution to Medicine Shortages or Political Manoeuvre?
New NIH Director Bertagnolli to Focus on Access
Hong Kong: A Blueprint for Innovation & Technology Transformation
Pharma Braces for Widespread Impact of US IRA
German Stakeholders Ramp up Critique of Proposed Healthcare Reform
Three Key Challenges for France’s New Health Minister
Morocco: Major Healthcare Reform Receives World Bank Backing
New EFPIA Board Tackles EU Pharma Legislation Reform
Innovators Slam EU Pharma Overhaul while Generics Industry & Patient Groups Applaud
Pharma Gets to Grips with the Inflation Reduction Act
The Inflation Reduction Act & the Economics of Drug Development
Understaffed if not Deserted: What’s Ailing French Healthcare?
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here